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ABSTRACT 
 
 
Brevetoxins are natural neurotoxins that are produced by “red tide” algae. In this study, 
brevetoxin-1 and brevetoxin-2 were incubated with rat liver hepatocytes and rat liver 
microsomes, respectively. After clean-up steps, samples were analyzed by liquid 
chromatography-electrospray mass spectrometry (LC-ES-MS). Two metabolites were found for 
brevetoxin-1: brevetoxin-1-M1 (MW 900 Da), formed by converting one double bond in the E or 
F ring into a diol; and brevetoxin-1-M2 (MW 884 Da), a hydrolysis product of brevetoxin-1 
involving opening of the lactone ring. The incubation study of brevetoxin-2 found two 
metabolites. Brevetoxin-2-M1 (MW 912 Da) was elucidated by negative mode LC-MS/MS to be 
the hydrolysis product of brevetoxin-2. The second metabolite (brevetoxin-2-M2, MW 896 Da) 
was deduced to be brevetoxin-3.  
All brevetoxins have high affinities for sodium ions. Attempts to obtain informative product ions 
from the collision induced decomposition (CID) of [M + Na]+ brevetoxin precursor ions only 
resulted in uninformative sodium ion signals. In our nano-electrospray experiments, the addition 
of ammonium fluoride resulted in the formation of the ammonium adduct or protonated 
brevetoxin with a concomitant decrease of the sodium adduct peak. Product ion spectra of [M + 
NH4]+ and [M + H]+ were similar and provided useful structural information. The optimal values 
for ammonium fluoride concentration and the cone voltage were experimentally determined. In 
negative mode electrospray, without additives, deprotonated molecules of brevetoxins do not 
appear in high abundances, and thus are not well-suited for CID experiments. Several anions 
were tested for their abilities to form brevetoxin-anion adducts by mixing ammonium salts of 
these anions with brevetoxin-2 and brevetoxin-3. Under CID, [M + Cl]-, [M + Br]-, [M + OAc]-, 
[M + HCOO]-, [M + NO3]- adducts all produced only the respective anions in CID experiments, 
 v
and thus, gave no structural information. In contrast, upon CID, both [M + F]- and [M + HCO3]- 
precursor adducts gave structurally-informative fragment peaks that exhibited similarities to 
those of  [M - H]- ions; the detailed fragmentation mechanisms are discussed. In comparison, 
fluoride is a better choice to study brevetoxins in negative ES-MS by the anionic adduct 
approach. 
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INTRODUCTION 
 
A Brief History of Electrospray Mass Spectrometry 
 
As an important analytical technique, mass spectrometry has a history of nearly one hundred 
years. J. J. Thomson won the Nobel Prize for his pioneering research in mass spectrometry. The 
first practical ionization source is electron impact or electron ionization (EI) source, which was 
first used by Dempster [1] and later developed by Nier [2]. For a long time, EI has been a 
standard ionization method for mass spectrometry. In 1966, Munson and Field [3] introduced  
chemical ionization (CI) to ionize molecules. Instead of by electron impact, the new technique 
generates characteristic ions of sample by ion-molecule reactions, a “softer” way of ionization. 
However, both methods require analyte to be volatile, limiting the technique to only a small 
fraction of organic compounds. 
 
A revolution of mass spectrometry took place in the 1980’s, electrospray ionization (ESI) [4]and 
matrix assistance laser desorption ionization (MALDI)  [5, 6] were developed and widely 
accepted. ESI makes it practical to couple liquid chromatography with mass spectrometry (LC-
MS).  A wide range of compounds, from a hundred Dalton (small molecules) to macromolecules 
like proteins, can be introduced into the mass spectrometer by this ionization technique. 
 
Electrospray as a phenomenon was observed long time ago. As early as the 1910’s, physicist 
John Zeleny already reported a solution could be sprayed from a capillary when high voltage was 
applied [7, 8]. Malcom Dole and coworkers made the first attempt to couple this method with a 
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mass spectrometer [9]. Dole showed that it was possible to electrospray solutions of polystyrene 
with an average mass of 51k Da, and the desolvated ions could be measured based on their mass 
over charge ratio (m/z).  
 
However, after Dole’s work, research on electrospray as an ionization source became dormant. 
The real breakthrough came in 1980’s, John Fenn, by then close to his retirement age at Yale’s 
Department of Engineering and Applied Science, began to investigate ESI as an ion source for 
LC/MS interface, a great work that later lead to his receiving the Noble Prize. Fenn introduced 
bath gas into the ESI source to promote the desolvation of analyte solution droplets. He started 
with smaller molecules, but eventually achieved success with biomolecules, instead of the 
polymers that Dole used as study subjects [10, 11]. While John Fenn successfully developed 
electrosray ionization source in the US, at almost the same time, a group of Russian scientists 
also developed their ESI source independently [12]. 
 
In the 1990’s, several attempts were made to combine ESI to several different mass analyzers. 
Besides John Fenn’s established ESI-quadrupole arrangement, McLafferty and co-workers 
developed the ESI-FTICR interface; this combination allows high resolution and high mass 
range analysis. Larsen and McEwen [13, 14] developed an ESI/magnetic sector mass 
spectrometer, there are also several reports on ESI-TOF system[15-17], a combination that offers 
“unlimited” mass range and high mass accuracy at relatively low cost, and ESI coupling with the 
ion trap instrument [18, 19], a system that can perform multi-stage MSn experiments. 
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Today, ESI has become one of the most important mass spectrometry ionization techniques and 
it has been applied to a wide range of research areas, from small molecules like pharmaceutical 
ingredients[20], organmetallic compounds [21] to macromolecules like polymers[22] and 
proteins[23]. 
 
 
Mechanistic Aspects of Electrospray 
 
In electrospray, when a positive potential is applied to the solution in a capillary, driven by the 
electrophoresis of electrolytes, cations will migrate towards the outlet while anions will move in 
the opposite direction, thus, accumulating a net positive charge at the outlet tip. When the 
electrostatic forces and the surface tension reach a balance, the liquid will form a fully conical 
shape towards the counter electrode at the outlet, i.e., the so-called “Taylor cone”[24].The 
solution is dispersed into droplets from the cone tip, carrying net positive charges (in negative 
mode, the net charge is negative)[25]. The excess charges will be distributed on the surface of 
the droplet due to repulsive coulombic forces[26, 27].In the mean time, analyte molecules are 
also moving towards the surface until the partition between analytes on the surface and those 
inside the droplet reaches the equilibrium[28-31]. The surface activity of an analyte is an 
important factor to affect its electrospray signal in ESI-MS[32-35]. 
 
The behavior of charged droplets was studied by Lord Rayleigh as early as 1882[36]. Rayleigh 
developed his theory that predicts a droplet becoming unstable when the net charge of the droplet 
exceeds the limit, now known as the “Rayleigh limit”. Such a limit can be reached by either 
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shrinking the droplet by evaporation or by applying excess charge. Once the net charge is above 
the limit, the droplet will break up into fine droplets, a process referred to as a “Rayleigh 
discharge” or “Coulomb fission”[37, 38]. 
 
The detailed mechanism of a droplet’s evolution during its voyage from the liquid phase to the 
gas phase to finally generate the solute ion has been the subject of a large number of 
investigations and discussions, and even debates [37, 39, 40]. Two main theories have been 
proposed to explain the process. The ion evaporation model (IEM) and the charged residue 
model (CRM). Introduced by Iribarne and Thomson, the ion evaporation model predicts that the 
electric field on a droplet surface increases during droplet evaporation, and becomes strong 
enough to overcome the solvation forces and finally desorb solute ions from droplet surface into 
the gas phase[41-43]. The charged residue model, first proposed by Dole and co-workers, on the 
other hand, assumes that solvent evaporation will yield Coulomb fission due to Rayleigh 
instability. Such fission will repeat over and over and result in an ultimate droplet, containing 
only one molecule of solute, which in the end retains the droplet’s charge when the last solvent 
molecule evaporates [9, 44]. These two models each have supporting evidence and they cannot 
rule each other out. In general, the formation of small molecule ions is more likely via ion 
evaporation model[45], while that of macromolecule ion is more likely via the charged residue 
model[46, 47].   
 
In the gas phase, ion clusters, gaseous ions, neutral molecules and clusters are still under 
atmospheric pressure condition and will undergo a lot of low-energy collision. A molecule can 
be protonated or deprotonated by proton transfer reaction. The proton affinity of an analyte can 
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be defined as the negative of the enthalpy change of its protonation reaction. A protonated 
molecule may lose its proton to another molecule if the latter one has higher proton affinity [48-
51]. 
 
 
Electrospray and LC/MS 
 
Electrospray also has made it convenient interface to couple reversed phase high performance 
liquid chromatography (RP-HPLC) with mass spectrometry. Coupling chromatographic 
techniques and mass spectrometry will combine both the power of separation and the capability 
of structure identification, which makes it a versatile combination. GC-MS is the first practical 
instrument to use this concept. However, the majority of organic compounds are not volatile and 
can only be analyzed by liquid chromatography rather than gas chromatography. When EI and 
CI were the only ionization techniques available, LC-MS was quite challenging due to the 
difficulty to introduce LC eluant into a high vacuum EI or CI source. It was not until the 1970s 
that LC-MS drew more and more research interest. Scott et al. introduced the concept of moving-
wire interface[52], and later on, the first commercial LC-MS with moving belt interface was 
marketed by Finnigan Instrument (now part of Thermo-Fisher)[53, 54]. Such interfacing 
provided the capability of generating EI or CI spectra; EI is advantageous for library structure 
searching. However, the interface is quite expensive and technically demanding, and still 
requires a narrow range of volatility for analytes: compounds with low volatility are difficult to 
remove from the belt; highly volatile compounds, on the other hand, may be lost from the belt 
before entering the instrument[55]. 
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 The development of electrospray ionization provided a new approach for LC-MS interfacing. It 
can ionize non-volatile analytes under relatively low temperature, a quite desirable ionization 
technique for the majority of biomedical samples, which are usually polar and thermally-labile. 
One difficulty to combine LC with ESI-MS directly is the difference between the high flow rate 
of LC (1 mL/min from a conventional LC column) and the low flow rate of ESI (2-10 μL/min). 
Bruins introduced pneumatically-assisted electrospray technique (commercialized as IonSpray®) 
to accommodate higher flow rates[56, 57]. With the support of a stream of coaxial inert gas, 
usually nitrogen, such a design can hold a flow rate of up to 0.2 mL/min, which is compatible 
with 2 mm ID LC column and still offers a stable spray[58-60]. If an additional heating device is 
introduced around the spray capillary that heats the surrounding air to about 250 °C, the flow rate 
can be as high as 2 mL/min[61].  
 
In addition, instrument companies also develop techniques (under different trade names) to get 
rid of most of the large droplets and only allow a small part of charged droplets to reach the first 
vacuum stage of the mass spectrometer (for example, Z-Spray® by Micomass/Waters), which is 
a different approach to accommodate high flow rates. Nowadays, LC-ESI-MS has become one of 
the most widely applied techniques in biomedical research [62-64]. 
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Nano-electrospray 
 
One challenge faced by analysts in proteomics studies is the small amounts of analyte in 
biological samples, in some cases, less then ten micro-liters. While the optimum flow rate for 
conventional ESI is usually 2-10 μL/min, such amounts of sample would not provide analysis 
time long enough to accomplish tuning and data acquisition, and diluting the sample to obtain a 
larger volume usually would not solve the problem either.  
 
 In 1994, Emmet and Caprioli developed a “micro-electrospray” device, using a fused silica 
capillary with a smaller inner diameter. It can reduce the sample flow rate to 0.1 μL/min[65]. 
Later, the real innovation called “nano-electrospray” (nano-ESI) came in 1996, made by Wilm 
and Mann, they used disposable glass capillary tips as electrospray emitters, which are drawn out 
at one end to give orifices of 1-10 μm in diameter. Metal films (e.g., gold) are usually coated on 
the outside of the emitter to get sufficient conductivity. The emitters are loaded with sample from 
1-5 μL by a special gel loader tip. When high voltage is applied, the electric field will generate 
an electrospray flow of 20-50 nL/min; sometimes a low back pressure to the emitter is helpful to 
initiate the flow. Therefore, a 1 μL sample can last for 20 minutes or even longer, which is 
sufficient to record positive and negative signals and conduct MS/MS, even MSn experiments. 
 
Unlike micro-electrospray, which is more or less a low-flow conventional electrospray, nano-
electrospray shows some fundamental advantages.  Since nano-ESI starts with the droplets much 
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smaller than those made by conventional ESI (0.1-0.2 μm vs 1-2 μm in diameter), therefore, 
unlike conventional ESI, where droplets undergo solvent evaporation, then uneven fission, 
yielding second generation droplets, the droplets produced by nano-ESI can be one generation 
less than those produced by conventional ESI, which helps to obtain good signals from 
complicated biological samples [66]. Juraschek et al reported that nano-electrospray gave 
satisfactory results for insulin samples containing 10 mM NaCl, while using conventional ESI, 
no useful data was obtained[67]. 
 
Physiological Effects of Brevetoxins. 
 
Brevetoxins are natural toxins that are produced from a single cell dinoflagellate Karenia brevis  
that is responsible for blooms of “red tide” algae[68], red tide can cause massive fish kills and 
human health hazard. The physiological effects of brevetoxins are mainly neurotoxic symptoms 
in animals and humans. This type of toxin can induce central depression of respiratory and 
cardiac functions, spontaneous muscle contractions, spasms and rhinorrhea[69]. The toxicity of 
brrevetoxins stems from the fact that they bind to a specific receptor site in the voltage sensitive 
sodium channel (VSSC) in the cell membrane[70]. Binding involves a complicated series of 
association-dissociation events, and the whole binding process may need several hours to reach 
equilibrium [71]. It is hypothesized that the binding of brevetoxins to this VSSC receptor site 
will push the channel in favor of its open conformation, thus shifting the channel activation 
voltage and prolonging the activation duration time, while inhibiting its inactivation 
function[72]. Over time, cells can no longer conduct their functions properly, and many 
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symptoms such as hypertension and arrhythmia will occur. In clinical animal trials, the 
symptoms could lead to death[69]. 
 
 
 
Microsomes and Hepatocytes 
 
Because liver is the major organ for toxic chemical biotransformations, it is the tissue of choice 
for metabolism and toxicity studies. Due to the limited availability of human liver tissue, rat, a 
species that may genetically approximate humans, is widely used in the pharmaceutical industry 
for in vivo metabolism studies and its liver tissue used in in vitro metabolism screening [73].  
The metabolite profile of a drug obtained in vitro generally reflects the in vivo metabolite pattern, 
although results are limited to qualitative aspects[74]. Because of this, in vitro metabolism 
techniques involving liver tissue, including isolated liver hepatocytes and microsomes, have been 
developed[75]. Liver microsomes are prepared by homogenization of livers (fresh or frozen), 
followed by centrifugation of the homogenate at 9,000-10,000 times the force of gravity (9,000-
10,000 g) to precipitate the unbroken cells, nuclei and mitochondria, yield a supernatant 
subcellular fraction (also known as S9 or S10); further centrifugation such fraction at about 
100,000 g will yield a microsome pellet [76].  Microsomes contain many xenobiotic-
metabolizing enzymes, the most prominent group of enzymes is the family of cytochrome P450 
(CYPs). These enzymes play a key role in the metabolism of a variety of chemically diverse 
compounds.  
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Like liver microsomes, hepatocytes are also widely employed in in vitro metabolism studies. 
Hepatocytes are isolated from liver by so-called two-step collagenase digestion procedures. A 
freshly isolated liver is perfused first with an isotonic buffer solution containing a calcium 
chelating agent to clear the blood and to loosen cell-cell junctions, followed by a collagenase 
solution to dissociate the hepatocytes from the liver parenchyma [77]. Cryopreserved 
hepatocytes are also available, but some enzyme reactivity (including P450) might be lower than 
that of freshly isolated hepatocytes, and both types lose enzyme activity fairly rapidly with time. 
Due to this, and the commercial shortage of fresh liver, many laboratories favor liver 
microsomes since they can be prepared and purchased in large batches and preserved at –80 °C 
for many months with little loss of P450 activity [78]. However, hepatocytes are an integrated 
cellular system, which is closer to the real situation, and can demonstrate both phase I 
metabolism (oxidation, reduction or hydrolysis) and phase II metabolism (conjugate reactions of 
the parent or the metabolites from phase I), an advantage over microsomal systems since the 
latter can only provide information on phase I metabolism [79]. 
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Chapter I 
 
 
 
Characterization of Rat Liver Microsomal and Hepatocytal Metabolites of 
Brevetoxins by Liquid Chromatography-Electrospray Tandem Mass 
Spectrometry    
 
 
 
Abstract 
 
Brevetoxins are natural neurotoxins that are produced by “red tide” algae. This class of 
compounds can cause neurotoxic shellfish poisoning and other health problems. Brevetoxin-2 is 
the most abundant among the nine brevetoxins that have been characterized, whereas brevetoxin-
1 is the most toxic. In this study, brevetoxin-1 and brevetoxin-2 were incubated with rat liver 
hepatocytes and rat liver microsomes, respectively. After clean-up steps were taken to remove 
the proteins, samples were analyzed by liquid chromatography (LC) coupled with electrospray 
mass spectrometry (LC-MS). After incubation of brevetoxin-1, two metabolites were found: 
brevetoxin-1-M1 (molecular weight = 900 Da), and brevetoxin-1-M2 (molecular weight = 884 
Da). The increase in molecular weight combined with evidence from tandem mass spectrometry 
showing an increased tendency for loss of water molecules; along with considerations of 
established precedents for chemical transformations led to the conclusion that brevetoxin-1-M1 
was formed by converting one double bond in the E or F ring of brevetoxin-1 into a diol. The 
second metabolite (brevetoxin-1-M2) is proposed to be a hydrolysis product of brevetoxin-1 
involving opening of the lactone ring with the addition of a water molecule. The incubation study 
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of the other starting compound, i.e. brevetoxin-2 found two metabolites in the LC-ES-MS 
selected ion chromatogram. Brevetoxin-2-M1 (molecular weight = 912 Da) gave a large [M-H]- 
peak at m/z 911, and its product ion mass spectrum allowed the deduction that this metabolite 
was the hydrolysis product of brevetoxin-2 involving conversion of the lactone to a carboxylic 
acid and an alcohol. The second metabolite (brevetoxin-2-M2, molecular weight = 896 Da) was 
deduced to have the same structure as that of brevetoxin-3 based on identical chromatographic 
retention times and similar mass spectra as those obtained for a brevetoxin-3 standard. 
 
Keywords:    brevetoxins, red tide, metabolite, electrospray, LC-MS, mass spectrometry 
 
 
 
 
 
1.1 Introduction 
 
Brevetoxins are natural toxins that are produced from a single cell dinoflagellate Karenia brevis 
(formerly known as Ptychodiscus brevis and Gymnodinium breve) that is responsible for blooms 
of “red tide” algae [1, 2]. This algae can grow rapidly under appropriate conditions of nitrate 
concentration, salinity, water depth and other factors [3].  Outbreaks of  “red tide” have been a 
recurring problem in the Gulf of Mexico in recent years. In fact, it is reported that since the 
1970s, the rate of reoccurrence of this harmful algal bloom in the US has increased. For example, 
the Karenia brevis outbreak off the western coast of Florida occurs every 3-5 years [4]. The 
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toxins produced from such algae are lipid soluble polyether neutrotoxins that can cause massive 
fish kills. They also can cause human health hazards such as food (shellfish) poisoning [5], 
respiratory problems, eye irritation and skin irritation[6-8]. Such harmful blooms usually impair 
the fishery industries (e.g. causing closing of shellfish beds), as well as the tourism industry.  For 
example, in October of 1996, a Karenia brevis bloom occurred in the shellfish harvesting waters 
(Gulf of Mexico) off of Louisiana, Mississippi and Alabama. Brevetoxin-2 dominated the 
Karenia brevis toxin profile in the bloom, and shellfish toxicity exceeded the guidance level for 
75 days even after the bloom had dissipated [9]. Also in the spring of that same year, a bloom of 
Karenia brevis appeared along the southwest coast of Florida, and at least two hundred manatees 
were found dead or dying in the coastal waters, or on beaches, in an ecological disaster[10]. The 
physiological effects of brevetoxins are mainly neurotoxic symptoms in animals and humans. 
This type of toxin can induce central depression of respiratory and cardiac functions, 
spontaneous muscle contractions, spasms, rhinorrhea, and the symptoms sometimes led to 
death[11]. 
 
The structures of brevetoxins are complicated and their molecular weights are nearly 1000 Da, so 
the structural elucidation of these compounds is quite challenging. In 1981, Lin et al. [12] first 
reported the structural identification of brevetoxin-2, the most naturally abundant brevetoxin 
species. Since then, there are a total of nine brevetoxins that have been structurally elucidated[5, 
13, 14]. Based on their backbone structures, they can be divided into two categories (Figure 1.1): 
type A, which has 10 polyether rings; and type B, which has 11 polyether rings.   
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 Currently, there are only a few reports on metabolite studies of brevetoxins, and these mainly 
pertain to metabolites found in shellfish. A case study of shellfish poisoning in Florida found 
four major metabolites by HPLC-MS and radioimmunoassy[15]. One is identified as brevetoxin-
3, which was likely produced by reduction of the dominant parent toxin brevetoxin-2. When 
detected in the form of protonated molecules, [M+H]+, the remaining three metabolites appeared 
at m/z 1018, 1034 and 1006. Two of these metabolites were recently identified as a cysteine 
conjugate (m/z 1018) and its sulfoxide form (m/z 1034) of brevetoxin-2 [16]. In addition, that 
same recent study assigned m/z 990 and m/z 1006 as a cysteine-brevetoxin-1 conjugate and its 
sulfoxide, respectively.  In 1993, more than 280 people suffered from shellfish poisoning in New 
Zealand in a single incident[17, 18] related to consumption of “Greenshell Mussels”. Two major 
metabolites were separated and identified: One appeared at m/z 1135.7 in negative mode FAB-
MS. Combined with information obtained from NMR studies, the structure was determined to be  
 
a D-ring opening of brevetoxin-2 with esterification of the resulting alcohol and oxidation of the 
terminal aldehyde to the acid form[17, 19]. The other metabolite appeared at m/z 1034.5 in its 
protonated form. It can be described as a 1,4-addition of L-cysteine to the terminal side chain 
group of brevetoxin-2 followed by oxidation of the sulfide to sulfoxide and reduction of the 
aldehyde to an alcohol. However, studies on the metabolic pathways of brevetoxins in 
mammalian species are still rare. An early study in 1989 reported the observation of two 
metabolic products in rat liver hepatocytes using a radiolabeled compound. However, the 
structures of these two metabolites were not elucidated[20].  
 
In the current study, rat liver microsomes were applied to the in vitro metabolism study of 
brevetoxin-2, the dominant species of brevetoxins, and high performance liquid chromatography  
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Figure 1.1. General structures of the two main types of brevetoxins 
 
 
 
 
 
 
 24
coupled with tandem mass spectrometry was used for separation and identification of metabolic 
products. In addition, brevetoxin-1 was incubated with rat hepatocytes and analyzed by similar 
LC-MS/MS approaches.  
 
 
2.2 Experimental Section     
 
Materials: Brevetoxin-1 was purchased from Chiral Corp. (Miami, FL), Brevetoxin-2 and 
brevetoxin-3 were purchased from CalBiochem (La Jolla, CA), HPLC-grade methanol and water 
were purchased from EM Sciences (Gibbstown, NJ). Rat hepatocyte wells were purchased from 
CEDRA Corp. (Austin, TX); rat liver microsomes and NADPH regenerated system were 
purchased from Genetest Corp. (Woburn, MA). 
 
Microsomal incubation: According to the basic approach of Degawa et al. [21] and Zhang et al. 
[22, 23], 2 μL of 5 mM brevetoxin-2 in ethanol was added to the incubation system as the 
substrate, the incubation mixture also included rat liver microsomes (at 1.5 mg/mL protein 
concentration), 16.5 mM glucose-6-phosphate, 16.5 mM magnesium chloride, and 70 mM 
potassium phosphate buffer (pH 7.4) to make 0.1 mL aliquots each containing 0.1 mM 
brevetoxin-2[22]. The incubation was conducted in a VWR 1225 (Cornelius, OR) water bath at 
37 °C for 12-24 hours. Blank and control incubations were also conducted, including incubation 
in the absence of microsomes, incubation in the absence of brevetoxin-2, and incubation in the 
absence of NADPH regenerating system. The incubation was stopped by adding an equal volume 
of ice cold methanol; the mixture was then vortexed and centrifuged, and the supernatant was 
passed through a Microcon YM-3 filter (Pittsburgh, PA) to further remove protein.  
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 Rat hepatocyte incubation: The procedure was based on the method of Ekwall et al. [24]. 
Substrate solution (10 μg brevetoxin in 1 mL William E medium) was added into a rat 
hepatocyte well containing about 1 million cells. After 24 hours incubation at 37 0C in a 5% CO2 
incubator, the incubation was stopped by adding 2 mL CH3CN. The solution was filtered (0.2 
μm) and evaporated to 0.8 mL to eliminate virtually all organic solvent[25]. Blank (hepatocyte 
incubation performed with no added brevetoxin) and control tests (brevetoxin-1 added after a 
blank incubation was quenched to check for the possibility of solution hydrolysis) were also 
performed. These controls insured that observed peaks actually corresponded to brevetoxin 
metabolites . The solution containing substrate and metabolites was cleaned up by solid phase 
extraction and concentrated to 100 μL prior to LC/MS analysis.  
 
 
LC-MS and LC-MS-MS Analyses: After incubation and protein clean-up, the brevetoxin-2 
incubation sample was separated by liquid chromatography (LC) equipped with parallel LC-10 
ADVP pumps and a UV-Vis SPD-10ADVP detector (Shimadzu Instruments Co. Columbia, 
MD). A 2.1 x 100 mm, 3.5 μm C-18 Agilent (Wilmington, DE) LC column, coupled with 2.1 x 
12.5 mm Agilent (Wilmington, DE) C-18 guard column was employed to separate the mixture. 
The mobile phase was 80:20 methanol:water for the first 2.5 minutes, then linearly changed to 
90:10 methanol:water in one minute. The flow rate was set at 0.2 mL/min. The brevetoxin-1 
sample was separated on a 1 x 100 mm, 3 μm C-18 Spherisorb column (ISCO, Lincoln, NE), 
with an isocratic mobile phase (85:15 methanol/water at 20 μL/min). After exiting the column, 
the LC eluents were directly infused into the Quatro II triple-quadrupole mass spectrometer,  
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Figure 1.2. LC-MS chromatograms for brevetoxin-2 rat microsomes incubation 
sample and a brevetoxin-3 standard. a) TIC for incubation sample. b) SIC of m/z 
935 from the incubation sample. The peak at 4.31 min represents metabolite 
brevetoxin-2-M1.   c) SIC of m/z 919 from the incubation sample. In this 
chromatogram, the peak at 7.75 min represents a metabolite brevetoxin-2-M2, 
whereas the peak at 8.50 min is the M+2 peak of the sodium adduct of unreacted 
brevetoxin-2. d) SIC of m/z 917, [Brevetoxin-2 + Na]+, unreacted substrate from 
the incubation sample. e) TIC for brevetoxin-3 standard. The retention time of 
brevetoxin-3 overlaps that of brevetoxin-2-M2.  
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equipped with an electrospray ionization source (Micromass Inc. Manchester, UK). Nitrogen gas 
was employed as both drying gas and nebulizing gas. The ES “needle” voltage was set at 3.7 kV, 
and the cone voltage was set at 40 V, for both positive and negative modes. Collision-induced 
decomposition (CID) tandem mass spectra were acquired at 70-75 eV collision energy, using 
argon as collision gas at a pressure of 2.1 x 10-2 Pa (gauge external to cell). All mass spectra 
represent the average of 10 to 20 scans. M/z values were rounded down (truncated) to the nearest 
integer values, that is, the nominal mass of the fragment ions are reported in the spectra.  
 
1.3 Results and Discussion    
 
Brevetoxin-2 metabolism:  The LC-MS traces of the brevetoixn-2 sample incubated with rat 
microsomes are shown in Figure 1.2. Two main metabolite peaks were observed in addition to 
the peak representing unreacted brevetoxin-2. The averaged mass spectrum for the first 
chromatographic peak at 4.3 min (Figure 1.2b), representing the metabolite that we are calling 
brevetoxin-2-M1, showed mass spectral signals at both m/z 935 and 951 (Figure 1.3a), which 
suggested that these could be the sodium and potassium adducts, respectively, of a neutral 
molecule of 912 Da. The averaged mass spectrum for the second chromatographic peak at 7.8 
min (Figure 1.2c), which represents the second metabolite that we are calling brevetoxin-2-M2, 
showed m/z 919 as the base peak and also m/z 935 (Figure 1.3b). The third peak on the 
chromatogram at 8.5 min (Figure 1.2d) also showed two peaks, i.e., m/z 917 as base peak and 
m/z 933 (Figure 1.3c), which represent the sodium and potassium adducts of unreacted 
brevetoxin-2 in the incubation solution. Selected ion chromatograms of m/z 917 (Figure 1.2d) 
and 919 (Figure 1.2c), clearly show the peaks for sodium adducts of brevetoxin-2 and its  
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Figure 1.3. Mass spectra corresponding to major peaks observed in Figure 2. a) The 
peak at 4.3 min is assigned as Brevetoxin-2-M1 (912 Da), the hydrolysis product of 
brevetoxin-2. m/z 935 and 951 correspond to sodium and potassium adducts, 
respectively; m/z 943 represents  [2brevetoxin-2-M1 + Na + K]2+. b) The peak at 7.8 
min is assigned as Brevetoxin-2-M2 (896 Da), a reduced form of brevetoxin-2, i.e., 
brevetoxin-3: m/z 919 represents [brevetoxin-2-M2 + Na]+, m/z 935 is [brevetoxin-2-
M2 + K]+, m/z 927 is the doubly charged dimer of the above two species, and m/z 951 
is [2brevetoxin-2-M2 + Na + MeOH]+.  c) The peak at 8.5 min corresponds to 
unreacted brevetoxin-2: m/z 917 represents [brevetoxin-2 + Na]+, m/z 933 is 
[brevetoxin-2 + K]+, m/z 925 is the doubly charged dimer of the above two species, 
and m/z 949 is [brevetoxin-2 + Na + MeOH]+. Note that each peak is shifted toward 
lower m/z by two units as compared to 3b. d) Brevetoxin-3 standard. m/z 919 is the 
sodium adduct of brevetoxin-3, and m/z 951 is the sodium-plus-methanol adduct of 
brevetoxin-3. 
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metabolite, respectively. No other significant peak was found by searching selected ion 
chromatograms of other m/z values, nor by extending the chromatographic running time. Based 
on this information, we postulate that the second chromatographic peak at 7.8 min corresponds to 
the sodium and potassium adducts of the metabolite brevetoxin-2-M2 of mass 896 Da, which has 
the same molecular weight as brevetoxin-3 (see Figure 1.1). 
 
 
We postulate that brevetxin-2-M2 is formed by metabolic reduction of the tail (addition of two 
hydrogen atoms to become the aldehyde), thereby forming brevetoxin-3. To confirm the 
postulation that the peak at 7.8 min (brevetoxin-2-M2, Figure 1.2) has the same structure as 
brevetoxin-3, LC-MS of a brevetoxin-3 standard in methanol (0.05 mM) was conducted, and its 
retention time (7.78 min figure 1.2e was found to be the same as that of brevetoxin-2-M2 under 
the same chromatographic conditions. The averaged mass spectrum of this standard (Figure 1.3d) 
also gave a signal at m/z 919, but did not give a strong signal at m/z 935 (no potassium adduct). 
This could be rationalized by considering that the brevetoxin-3 standard (with ubiquitous sodium 
contamination) was dissolved in pure methanol, whereas the incubation sample is actually in a 
solution of potassium phosphate buffer (pH 7.4). Brevetoxins have very strong binding affinities 
for sodium ion, and even trace levels of sodium in the system are already enough for brevetoxins 
to form sodium adducts[26]. Notably, peaks corresponding to noncovalent methanol addition to 
sodium adducts of brevetoxins were observed at m/z 951 in figure 1.3d, and  at m/z 949 in figure 
1.3c. Of course, these peaks appeared with the same retention times as the corresponding 
sodiated brevetoxin species. Lastly, doubly charged mixed adducts of brevetoxins containing 
Na+ and K+ were observed at m/z 943 in figure 1.3a, m/z 927 in figure 1.3b, and at m/z 925 in 
figure 1.3c [27]. 
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Figure 1.4: LC-MS/MS negative mode product ion mass spectrum of m/z 911, 
[brevetoxin-2-M1 - H]-. (inset figure, LC-MS negative ion mode chromatograms for 
brevetoxin-2 incubation sample. a) TIC; b) SIC for m/z 911, the deprotonated form 
of the metabolite Brevetoxin-2-M1. 
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 To further confirm the postulation that the second metabolite peak was brevetoxin-3, tandem 
mass spectrometry was performed. However, CID of the sodium adduct of brevetoxins only  
yields Na+, and no informative fragments[26]. In order to obtain a more useful tandem mass 
spectrum, protonated brevetoxin is a preferable precursor ion. In our study, both passing 
incubation mixture through the ionic exchange resin (Dowex 50WX8) and direct acidification 
with 0.4 M TFA were attempted to promote formation of protonated molecules; direct 
acidification yielded stronger signals, but the signal-to-noise ratios for protonated precursor 
molecules eluting during LC-MS were still not strong enough to obtain adequate product ion 
mass spectra. During the separation, apparently traces of sodium on the LC column and 
elsewhere converted protonated molecules back to sodium adducts. The approach of acidifying 
the mobile phase (by adding TFA) was also tried, but satisfactory [M + H]+ signals that would 
allow LC-MS/MS were still not obtained.  
 
The first metabolite peak (represented as brevetoxin-2-M1) has a deduced molecular weight of 
912 Da, 18 Da higher than the mass of brevetoxin-2. We propose that this metabolite is a 
hydrolyzed form of brevetoxin-2. In negative mode LC-ES-MS operation, the incubation sample 
showed a large chromatographic peak at 4.2 min (Figure 1.4 inset). The negative ion mass 
spectrum corresponding to this peak, shown in figure 1.4, reveals the [M-H]- counterpart, at m/z 
911, to the [M+Na]+ ion (m/z 935) already seen in figure 1.2b and 1.3a. The fact that the 
intensity of m/z 911 was so much higher than any of the brevetoxins and brevetoxin metabolites 
in the negative ion mode suggests that this metabolite is likely to be a carboxylic acid. In fact, 
neither brevetoxin-2 nor brevetoxin-3 in pure solvent gives a significant signal in negative mode  
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 Figure 1.5. Proposed fragmentation of [brevetoxin-2-M1 - H]- (m/z 911), 
leading to formation of m/z 893, 849, 795 and 777.  
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Figure 1.6. Proposed fragmentation mechanisms of [brevetoxin-2-M1 - H]- (m/z 
911), leading to formation of m/z 867, 113 and 69. 
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ES-MS. The problem is largely that the most acidic hydrogen atoms on brevetoxin-2 and 
brevetoxin-3 are the hydroxyl hydrogen atoms that are apparently not readily deprotonated under 
the employed negative ion electrospray conditions.  Tandem mass spectrometry of m/z 911 
(figure 1.4) provided further evidence to support our proposed structure. 
 
 
Figure 1.4 shows the LC-ES-MS/MS product ion spectrum of the m/z 911 precursor ion 
representing the deprotonated metabolite brevetoxin-2-M1. A charge remote fragmentation 
mechanism (Figure 1.5) can explain the formation of m/z 893 (by water loss), and subsequent 
charge induced CO2 loss leads to m/z 849. Alternatively, CO2 loss may occur first (yielding m/z 
867, figure 1.6) with water loss occurring afterwards to form m/z 849. The latter m/z 849 ion can 
undergo charge remote loss of a 54 Da neutral to form m/z 795 (Figure 1.5), with subsequent 
water loss to produce m/z 777 (Figure 1.5). At a CID energy of 75eV (ELAB), the hydrogen of the 
hydroxyl group on the B-ring may be transferred to the nearby carboxylic group (Figure 1.6 
middle panel), thereby initiating two possible fragmentation pathways leading to fragments at 
m/z 113, the largest fragment peak in the figure 1.4 product ion spectrum, and m/z 69 (Figure 
1.6). This same initial higher energy alkoxide form of m/z 911 is proposed to be responsible for 
the formation of m/z 85 (Figure 1.7), and m/z 127 (Figure 1.7). The latter can undergo CO2 loss 
to form m/z 83 (Figure 1.7). The brevetoxin-2-M1 metabolite is apparently formed by opening of 
the head lactone ring with concomitant addition of a water molecule.  This type of reaction can 
be accelerated by enzymes such as esterase or lactonase in the microsomes[28, 29].   
 
Brevetoxin-1 metabolism: After incubation of brevetoxin-1 with rat hepatocytes and clean-up, 
similar LC/MS approaches as above were applied to the analysis of the incubation samples. By  
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 Figure 1.8.  LC/MS selected ion chromatograms of brevetoxin-1 rat hepatocytes 
incubation sample. a) SIC of m/z 923, [Brevetoxin-1-M1 + Na]+. b) SIC of m/z 
907, [Brevetoxin-1-M2 + Na]+.  c) SIC of m/z 889, [Brevetoxin-1 + Na]+. 
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searching the entire range of masses contained in the total ion chromatogram, three ion peaks 
were revealed, and their single ion chromatograms are shown in figure 1.8 with peak retention   
times of 7.5 min, 8.0 min and 9.8 min in figure 1.8a, 1.8b, 1.8c, respectively. The peak retention 
time of 9.8 min in figure 1.8c and corresponding m/z value (889) are the same as those of the 
brevetoxin-1 standard starting material. This peak is clearly the sodium adduct [brevetoxin-1 + 
Na]+ of the remaining substrate. The peaks in figure 1.8a (assigned as [brevetoxin-1-M1+Na]+) 
and in figure 1.8b (assigned as [brevetoxin-1-M2 + Na]+) are proposed to be the sodiated forms 
of two brevetoxin-1 metabolites. To verify the mass assignment of the sodium adducts, the same 
solution was acidified by HCl addition (1:1 ratio of sample:0.33 M HCl), and the resultant 
solution was injected into the LC/MS system. The obtained selected ion chromatograms did 
show peaks corresponding to the mass of protonated species that appeared at the same time as 
the sodiated ions. The peak in figure 1.9b was assigned as [brevetoxin-1-M1 + H]+, and the peak 
in Figure 1.9d was assigned as [brevetoxin-1-M2 + H]+. The polarity of these two brevetoxin 
metabolites appears to be greater than that of precursor brevetoxin-1, as the latter eluted later 
from the reversed phase C-18 column. 
 
To gain more insight into the structure of brevetoxin-1-M1, the product ion tandem mass 
spectrum of the [brevetoxin-1-M1 + H]+ precursor was acquired and is shown in figure 1.10a. 
For comparison purposes, the product ion spectrum of the standard precursor [brevetoxin-1+H]+ 
obtained under identical instrumental conditions is given in figure 1.10b. While at least three 
consecutive water losses are detectable from [brevetoxin-1-M1 + H]+ (giving product ions at m/z 
849, 831 and 813 in figure 1.10b), the water losses are much more prominent relative to other 
fragmentations for [brevetoxin-1-M1 + H]+. In fact, the peak corresponding to loss of two water  
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 Figure 1.9. To examine the structures of metabolites, sample was acidified by 0.33 N 
HCl in a 1:1 ratio. The resultant solution showed peaks corresponding to protonated 
species that coexist with the sodiated ions in LC-MS. a). SIC for m/z 923, the peak of 
[Brevetoxin-1-M1 + Na]+. b) SIC for m/z 901, the peak of [Brevetoxin-1-M1 + H]+. c) 
SIC peak of [Brevetoxin-1-M2 + Na]+, m/z 907. d) SIC for m/z 885, [Brevetoxin-1-M2 
+ H]+. 
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Figure 1.10. LC-MS/MS product ion mass spectra. a) m/z 901, protonated brevetoxin-
1-M1 from incubation sample. b) m/z 867, [brevetoxin-1 + H]+ standard. 
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molecules (m/z 865) is even larger than the peak corresponding to a single water loss (m/z 883). 
Moreover, loss of a third water molecule (yielding m/z 847) gives a moderate signal relative to 
other product ions. The increased prominence of the second and third consecutive water losses 
for [brevetoxin-1-M1+H]+ combined with its higher mass (34 Da) relative to brevetoxin-1 leads 
us to propose that brevetoxin-1-M1 is an oxidation product resulting from the metabolic 
conversion of a double bond on brevetoxin-1 into a diol. The question becomes: which of the 
three double bonds is converted to the diol? 
 
In the lower ends of the product ion mass spectra, both figure 1.10a and 1.10b show peaks at m/z 
55, 81 and 95, these peaks are proposed to be characteristic of the brevetoxin-1 side chain 
(Figure 1.11). Because these same three peaks appear for decompositions of brevetoxin-1 and 
brevetoxin-1-M1, with no new peaks found for brevetoxin-1-M1 at m/z 89, 115 or 129, i.e., 34 
Da higher than the proposed “tail” fragments for brevetoxin-1, it seems unlikely that the “tail” 
side chain unsaturation on brevetoxin-1-M1 is the site of diol conversion. Rather, we propose 
that diol formation is occurring on one of the two double bonds on the E or F ring (structures 
shown in Figure 1.12). The mechanism could be described as a two-step reaction wherein the 
double bond is oxidized to form an epoxide structure catalyzed by enzyme P-450, followed by 
hydrolysis to form two hydroxyl groups. The structure of the second metabolite, i.e., brevetoxin-
1-M2, is proposed and shown in Figure 1.12. This metabolite is formed by opening of the lactone 
ring and by the addition of a water molecule. This kind of reaction can proceed spontaneously in 
aqueous solution and can be accelerated by enzymes such as esterases in the hepatocytes[30]. 
The reaction is very much analogous to that involved in brevetoxin-2-M1 formation from 
brevetoxin-2 except that there, an unsaturated six-membered ring lactone was involved; whereas  
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Figure 1.11. Proposed fragmentation mechanisms for “tail” portion side chain of 
[brevetoxin-1 + H]+ (m/z 867) leading to formation of m/z 55, 81 and 95. These 
three fragment ions also appear during CID of [brevetoxin-1-M1 + H]+ indicating 
that the side chain “tail” of the latter is the same as that of brevetoxin-1. 
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for brevetoxin-1, a saturated five-membered ring undergoes hydrolysis (see figure 1.1). While 
not reported for brevetoxin-1 and brevetoxin-2, similar hydrolytic opening of the A-ring was 
observed previously for brevetoxin metabolites isolated from oyster [16] such as the cysteine 
conjugate of brevetoxin-1 and brevetoxin-2, with molecular weights of 1008 and 1036 Da, 
respectively. 
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 Figure1.12. Proposed structures for the metabolites of brevetoxin-2 and 
brevetoxin-1. 
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 Conclusion     
 
LC/ES-MS and LC/ES-MS/MS have been shown to be useful tools for the characterization of 
brevetoxin metabolites. Brevetoxin-2 was shown to undergo in vitro metabolism by rat liver 
microsomes to yield two metabolites. One is assigned as the hydrolysis product of the head 
portion six-membered lactone ring of the substrate; the other is proposed to be brevetoxin-3, the 
metabolically reduced product of brevetoxin-2 (figure 1.12).  Brevetoxin-1 was shown to be 
metabolized by rat liver hepatocytes, also producing two metabolites. One is postulated to be 
formed by transforming a double bond on the E or F ring into a diol, while the other is proposed 
to be a hydrolysis product of brevetoxin-1 involving opening of the head group five-membered 
lactone ring (figure 1.12). 
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Chapter II 
 
 
 
 
Improved Collision Induced Decomposition Efficiency and Structural 
Assessment for “Red Tide” Brevetoxins employing Nano-electrospray Mass 
Spectrometry 
 
 
 
 
Abstract 
 
 
Brevetoxins are a group of natural neurotoxins found in blooms of red tide algae. Previous 
electrospray mass spectrometry (ES-MS) studies show that all brevetoxins have high affinities 
for sodium ions, and they form abundant sodium adduct ions, [M + Na]+, in ES-MS, even when 
trace contamination is the only source of sodium ion. Attempts to obtain informative product 
ions from the collision induced decomposition (CID) of [M + Na]+ brevetoxin precursor ions 
only resulted in uninformative sodium ion signals, even under elevated collision energies. In this 
study, a nano-ES-MS approach was developed wherein ammonium fluoride was used to form 
cationic [M + NH4]+ adducts of brevetoxin-2 and brevetoxin-3; a significant increase in the 
abundance of protonated brevetoxin molecules [M + H]+ also resulted, whereas the abundance of 
sodium adducts of brevetoxins [M + Na]+ was observed to decrease. Under CID, both [M + 
NH4]+ and [M + H]+ gave similar, abundant product ions and thus underwent the same types of 
fragmentation. This indicates that ammonium ions initially attached to brevetoxins forming [M + 
NH4]+ readily lose neutral ammonia in a first step in the gas phase, leaving protonated brevetoxin 
[M + H]+ to readily undergo further fragmentation under CID. 
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2.1 Introduction 
 
 
Brevetoxins are a class of natural marine toxins that are produced from the single cell 
dinoflagellate Karenia brevis.[1, 2] Under suitable conditions, the algae reproduce rapidly, 
causing the appearance of a “red tide” bloom [3]. Such outbreaks are responsible for large scale, 
periodic fish kills in the Gulf of Mexico and other salt water locations. The brevetoxins produced 
by a bloom of red tide can also lead to human health problems, such as neurotoxic shellfish 
poisoning (NSP) [4].  
 
Structurally, brevetoxins are classified as type A or Type B [5]. The compounds in the first 
category have 10 connected polyether rings, while the compounds in the second category have 
11 rings (Figure 1.1) [5, 6]. The molecular weights of brevetoxins are close to 1000 Da. A liquid 
chromatography-electrospray-mass spectrometry (LC-ES-MS) method was developed in our lab 
to analyze the various types of brevetoxins in “red tide” algae extracts [7, 8]. This circumvented 
the use of derivatizing agents that were employed during a previous HPLC-FAB-MS study of 
brevetoxin-3 [9]. 
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 LC-MS methods have also been employed to analyze metabolites of brevetoxins, in a NSP case 
study from Florida, Poli et al. [10] reported using LC-MS to identify brevetoxin-3, which was 
likely a metabolite of brevetoxin-2, in the extracts of contaminated shellfish samples. Plakas et 
al. [11] confirmed LC-MS fractions containing m/z 1018 and 1034 as protonated molecules of 
cysteine-brevetoxin and cysteine-brevetoxin sulfoxide conjugates, respectively, in the Eastern 
oyster (Crassostrea virginica) exposed to pure brevetoxin-2 and to a Karenia brevis culture. In a 
follow-up study, Wang et al. [12] identified a cysteine-brevetoxin conjugate and its sulfoxide 
with an A-type brevetoxin backbone as probable derivatives of brevetoxin-1 in Crassostrea 
virginica, as well as other metabolites such as glycine-cysteine-brevetoxin; γ-glutamyl-cysteine-
brevetoxin and glutathione-brevetoxin conjugates. In our lab, we performed in vitro incubations 
of brevetoxin-1 with rat liver hepatocytes, and brevetoxin-2 with rat liver microsomes, that 
resulted in hydrolytic lactone-ring opening products for both brevetoxins; brevetoxin-3 as 
metabolite of brevetoxin-2, and a metabolite of brevetoxin-1 postulated to have undergone a 
double bond transformation in the E or F ring, forming a diol [13]. 
 
Brevetoxins exhibit high affinities for sodium ions, and thus readily form sodium adducts [M + 
Na]+ that  dominate the electrospray mass spectra, even when only traces of sodium are present.  
Consequently, without further treatment, excellent sodium adduct signals may be obtained for all 
types of brevetoxins by electrospray mass spectrometry (ES-MS). The sodium adducts, however, 
did not yield structurally informative product ions by collision induced decomposition (CID), 
and only sodium ions were produced at high collision energies [14]. To promote the formation of 
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protonated molecules instead of sodiated ones, we added strong acid (HCl) to solutions 
containing brevetoxin [15]. 
 
This method succeeded in producing high levels of [M + H]+ ions that were quite susceptible to 
CID, thus providing structural information. A potential drawback, however, was that the acidic 
conditions required to sufficiently displace sodium cations by protons (i.e., pH ≈ 3) may be 
potentially deleterious to the sample and/or the instrument. Therefore, we searched for other 
means to enhance the yields of structurally informative fragments. In later work, Nozawa, Ishida 
and coworkers [16, 17] reported a LC-MS/MS method using an acidified acetonitrile mobile 
phase to identify and quantitatively determine brevetoxins found in shellfish following an 
outbreak of NSP in New Zealand. Optimum signal-to-noise ratios of [M + H]+ ions promoted by 
formic acid addition to either methanol or acetonitrile appeared quite comparable to one another 
[16]. 
 
Besides addition of acid, an alternative approach to reducing the abundance of sodium ion 
adducts and increasing the number of protonated molecules was proposed by Stark et al [18]. 
They found that adding ruthenium chloride to certain complex natural products could suppress 
the formation of sodium adducts and concomitantly increase the abundance of protonated 
molecules. However, the detailed mechanism underlying this phenomenon has not been fully 
elucidated. In our hands, the limited solubility of ruthenium chloride necessitated filtering of 
sample solutions prior to electrospray, and created a higher risk of source fouling (usually at the 
orifice of the sampling cone).    
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The strategy of adding ammonium ions to the electrospray solvent, to create a yield of 
ammonium adducts of certain analytes has also been documented. Fleet et al. [19] using direct 
infusion positive ES-MS, reported that chrysanthemic acid ester pyrethroid insecticides yielded 
[M + H]+ and [M + NH4]+ ions in an isopropanol water/formic acid/ammonium acetate 
environment, and found [M + NH4]+ underwent source-derived CID at high “cone” voltages and 
yielded [M + H]+ and diagnostic fragment ions. Yin et al. [20] studied a series of peroxides by 
ES-MS that were found to form ammonium adducts from a methanol/water (50:50) solution with 
10 mM ammonium acetate; CID experiments on [M + NH4]+ precursor ions were shown to give 
informative fragments.  
 
In the current study, ammonium fluoride was used as an additive to study solutions containing 
brevetoxins. Low flow ES, also known as “nanoelectrospray” was employed to generate mass 
spectra, including CID experiments. Since Wilm and Mann [21] developed the idea of solvent 
pump-free nanoelectrospray in 1996, the approach has been widely used in both direct infusion 
MS analyses and on-line LC-MS applications. Different from conventional electrospray that runs 
at a flow rate of about 5 uL/min and forms 1-2 um diameter liquid droplets, nanoelectrospray can 
run at flow rates as low as 20 nL/min and creates droplets of less than 200 nm diameter, which 
improves the ionization efficiency because of the greater surface-volume ratio.  This low flow 
rate dramatically reduces sample consumption and greatly prolongs the available analysis time 
for scarce and/or valuable samples [22].  Because of the prohibitively expensive cost of 
commercially-available brevetoxins, the use of nanoelectrospray turned out to be particularly 
advantageous. 
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2.2 Experimental 
 
Brevetoxins were purchased from CalBiochem (La Jolla, CA), and ammonium fluoride, 
ammonium acetate, ammonium chloride were purchased from Aldrich (Milwaukee, WI). 
Nanospray tips were purchased from New Objective (Woburn, MA); the diameter of the 
employed tip orifice was 4 μm. All mass spectrometry experiments were performed on a Quattro 
II triple quadrupole mass spectrometer (Micromass, Inc., Manchester, UK) equipped with a 
direct infusion nanospray assembly. The “needle” voltage was set at 1.6-1.8 kV, and the source 
temperature was set at 30 ºC. All mass spectra represent the average of 20 scans or more; the m/z 
values were rounded down (truncated) to the nearest integer values, i.e., the nominal masses of 
the detected ions are reported in the spectra. 
 
2.3 Results and Discussion 
 
In conventional ES-MS analyses, aqueous/organic mixtures, sometimes with weak acid 
additives, are the most frequently used solvents for positive mode analysis. However, due to their 
high affinities for sodium ions, it is very difficult for brevetoxins to yield highly abundant 
protonated molecules under such conditions (Figure 2.1a). In previous studies in our lab, strong 
acid addition (i.e. trifluoroacetic acid or hydrochloric acid) was used to suppress the appearance 
of sodium adducts by favoring production of protonated molecules [15] In this paper, we present 
an alternative approach, i.e., that of adding ammonium ions to compete with the formation of 
brevetoxin-sodium adducts. 
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Figure 2.1. Electrospray mass spectra of brevetoxin-3 as a function of ammonium 
fluoride addition. The concentration of brevetoxin-3 was set at 5 x 10-5 M in a 1:1 
water/methanol solution, and the concentration of ammonium fluoride was at (A) 0,   
(B) 2 x 10-4 M, and (C) 5 x 10-4 M. The peak at m/z 908 is assigned as [2brevetoxin-3 
+ Na + H]2+. The abundance of protonated brevetoxin-3 (m/z 897) increased, and that 
of [brevetoxin-3 + Na]+ (m/z 919) decreased, as the concentration of ammonium ions, 
introduced as NH4F, was raised. 
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Figure 2.1a displays the mass spectrum of brevetoxin-3 (a neutral molecule of 896 Da) dissolved 
in 1:1 (water:methanol), showing a low abundance of [brevetoxin-3 + H]+ at m/z 897, and a high 
abundance of the sodium adduct [brevetoxin-3 + Na]+ at m/z 919. The source of sodium ions is 
the ubiquitous trace level contamination of sodium in the solvent and elsewhere. As ammonium 
fluoride is added to the system, and the molar ratio of ammonium ion vs brevetoxin-3 reaches  
4:1 (Figure 2.1b), the abundance of [brevetoxin-3 + H]+ in the spectrum rises to a level 
comparable to that of [brevetoxin-3 + Na]+, with the ammonium adduct [brevetoxin-3 + NH4]+ at 
m/z 914 now appearing in a moderate abundance. As addition of ammonium fluoride continues 
to 10:1, [brevetoxin-3 + H]+ at m/z 897 becomes the base peak (Figure 2.1c), while the relative 
abundance of [brevetoxin-3 + Na]+ (m/z 919) continues to descend. A similar result (not shown) 
was achieved for ammonium fluoride addition to brevetoxin-2, a compound having a similar 
structure to brevetoxin-3, except that the former contains an aldehyde functionality in place of an 
alcohol group in the “tail” portion (see Figure 1). Notably, ammonium acetate and ammonium 
chloride were also tried in place of ammonium fluoride, and similar adducts were observed in 
positive ion ES mass spectra. 
 
An important parameter to influence relative signal intensities in ES-MS is the “cone” voltage 
(nozzle-skimmer differential). Detailed studies showing the abundances of the three adducts of 
interest vs cone voltage appear in Figure 2.2a and 2.2b. In a water/methanol environment, with a 
ten-fold excess of ammonium fluoride relative to brevetoxin-2 (894 Da neutral) the [brevetoxin-2 
+ NH4]+ adduct (m/z 912) is readily formed, and at low cone voltage (5 V) it dominates as the 
base peak (Figure 2.2a). As the cone voltage is increased, the abundance of the ammonium 
adduct first climbs rapidly, reaches a maximum at 20 V, then drops off at higher voltage values.  
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Figure 2.2. Ion abundance vs. cone voltage for brevetoxins molecular ions from a 1:1 
water/methanol system containing (a) 5 x 10-5 M brevetoxin-2 and 5 x 10-4 M NH4F; 
(b) 5 x 10-5 M brevetoxin-3 and 5 x 10-4 M NH4F. The abundances of [brevetoxin-2 + 
NH4]+ and [brevetoxin-3 + NH4]+ reached their maxima at 20 V, whereas those of 
[brevetoxin-2 + H]+ and [brevetoxin-3 + H]+ reached their maxima at 35 V. 
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On the other hand, protonated brevetoxin-2, [brevetoxin-2 + H]+ at m/z 895, is barely visible at 5 
V; as the cone voltage rises, the abundance of m/z 895 increases slowly at first, then more 
quickly, reaching its maximum at 35 V. The decrease of the ammonium adduct (m/z 912) and 
concurrent increase in [brevetoxin-2 + H]+ (m/z 895) between 20 and 35 V is attributed to a 
decomposition of the former via loss of ammonia, thereby forming the latter. Above 35V, the 
increasing nozzle-skimmer differential results in fragmentation of protonated brevetoxin-2, 
leading to an abundance drop for [brevetoxin-2 + H]+. On the other hand, the sodium adduct of 
brevetoxin-2 is a much more robust adduct than [brevetoxin-2 + NH4]+ or [brevetoxin-2 + H]+, 
and the abundance of [brevetoxin-2 + Na]+ (m/z 917) shows a much slower decrease with the 
rising cone voltage beyond its maximum at 45 V. 
 
An analogous experiment conducted using brevetoxin-3 in place of bevetoxin-2 showed a similar 
result (Figure 2.2b), where the abundance of the ammonium adduct [brevetoxin-3 + NH4]+ (m/z 
914) reaches its peak at a cone voltage of 20 V, and production of protonated brevetoxin-3 
[brevetoxin-3 + H]+ (m/z 897) reaches an optimum at 35 V; the higher stability sodium adduct 
[brevetoxin-3 + Na]+ (m/z 919) exhibits its maximum at 45 V. 
 
In order to optimize the addition of ammonium ions, a detailed study of adduct abundances as a 
function of initial ammonium concentration was conducted. Employing a fixed cone voltage of 
20 V, i.e., Figure 2.2b’s optimum value for the [brevetoxin-3 + NH4]+ (ammonium-brevetoxin-3 
adduct), the absolute intensities of the same three ions of interest were monitored using 
increasing concentrations of ammonium fluoride and a fixed concentration of brevetoxin-3 (5 x 
10-5 M); a single nanospray tip was used throughout the entire experiment. Figure 2.3a shows  
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Figure 2.3. Absolute abundances of molecular ions of brevetoxin-3 vs molar ratio 
ammonium fluoride : brevetoxin-3. The concentration of brevetoxin-3 was set at 5 x 
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voltage was set at (a) 20 V and (b) 35 V. 
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that when brevetoxin-3 is dissolved in 1:1 methanol:water (no added ammonium fluoride), the 
m/z 919 sodium adduct [brevetoxin-3 + Na]+ (sodium from the environment) dominates the mass 
spectrum, while protonated brevetoxin-3 appears in very low abundance. However, as 
ammonium fluoride addition starts, the abundance of [brevetoxin-3 + Na]+ begins to drop 
significantly while [brevetoxin-3 + NH4]+ at m/z 914 climbs dramatically. When the molar ratio 
of ammonium:brevetoxin-3 goes beyond 3:1, the abundance of [brevetoxin-3 + NH4]+ surpasses 
that of [brevetoxin-3 + Na]+, and ammonium adducts become the base peak in the spectrum. The 
abundance of [brevetoxin-3 + NH4]+ keeps increasing until the molar ratio reaches 10:1, where 
leveling off occurs. Meanwhile, the abundance of [brevetoxin-3 + Na]+ steadily declines until the 
10:1 ratio is reached; beyond this point its signal levels off. This experiment indicates that, in 
order to observe the maximum [brevetoxin-3 + NH4]+ signal, the optimum 
ammonium:brevetoxin-3 molar ratio should be about 10:1. Beyond this value, the ionic strength 
of the solution is needlessly increased. 
 
An analogous experiment was conducted at a higher cone voltage, 35 V, the optimum value for 
observation of protonated brevetoxin-3 [brevetoxin-3 + H]+ (see Figure 2.2b). Figure 2.3b shows 
that at 35 V, when brevetoxin-3 is dissolved in 1:1 methanol:water (no added NH4F),  
[brevetoxin-3 + H]+ at m/z 897 appears in only minor abundance while [brevetoxin-3 + Na]+ at 
m/z 919 dominates as the base peak (also seen in Figure 2.1a). As the addition of ammonium 
fluoride starts, the abundance of protonated molecules [M + H]+ increases almost linearly with 
molar ratio (ammonium:brevetoxin-3) in the range of 1 to 8. A further molar ratio increase 
beyond 10 does not result in a significant change of the abundance. The ammonium adduct 
[brevetoxin-3 + NH4]+ at m/z 914 follows a similar trend, except that it appears in lower  
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abundance at each molar ratio (the cone voltage is not set at the optimal value for preservation of 
the ammonium adduct). The sodium adduct [brevetoxin-3 + Na]+ at m/z 919 displays an opposite 
trend: it shows high abundance before ammonium addition, and its abundance decreases rapidly 
upon addition; it levels off when the molar ratio goes beyond 8:1. Figure 2.3b shows that the 
optimum molar ratio to observe protonated brevetoxin-3 is 10:1 (ammonium fluoride:brevetoxin-
3). Analogous experiments monitoring adduct signals as a function of ammonium fluoride 
addition were conducted for brevetoxin-2. Figures 2.4a and 2.4b show that the optimum molar 
ratio is again approximately 10:1 (ammonium fluoride:brevetoxin-2) for appearance of either 
[brevetoxin-2 + NH4]+ or [brevetoxin-2 + H]+ at cone voltages of 20 V or 35 V, respectively.  
 
Yin et al. [20] reported that under appropriate CID conditions, ammonium adducts of peroxides 
could undergo fragmentation to yield fragment ions that incorporate the ammonium ion. In the 
current study, the product ion scan of the [brevetoxin-3 + NH4]+ precursor is shown in Figure 
2.5a. When compared to Figure 2.5b, the analogous product ion spectrum of protonated 
brevetoxin-3 [brevetoxin-3 + H]+, the similarities in fragment ions formed via CID are obvious. 
In addition, the spectra are devoid of even mass ions, which indicates that the ammonium ion is 
not incorporated in any of the Figure 2.5a fragments. These observations indicate that the first 
decomposition step for the [brevetoxin-3 + NH4]+ precursor is loss of a neutral ammonia 
molecule. Afterwards, consecutive decompositions take place from the remaining protonated 
brevetoxin-3, hence, the similarity in the products formed.  
 
Figures 2.6a and 2.6b, the product ion mass spectra generated from the ammonium-brevetoxin-2 
adduct and protonated brevetoxin-2, respectively, also share similar fragment ions with one  
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Figure2.5. Product ion spectra showing CID of (a) m/z 914 precursor, the 
ammonium adduct of brevetoxin-3, [brevetoxin-3 + NH4]+; and (b) m/z 897 
precursor, protonated brevetoxin-3, [brevetoxin-3 + H]+. The similarity of these two 
spectra indicates that the ammonium adduct loses NH3 rapidly, then other 
(consecutive) decompositions occur from the remaining protonated species. 
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another. Similar to the above findings, no ammonium-containing fragments are observed in 
Figure 2.6a. These findings indicate that the first step for CID of [brevetoxin-2 + NH4]+ is 
ammonia loss, leaving the protonated molecule to undergo consecutive decompositions.  
 
Detailed mechanisms to rationalize fragmentations of the two studied brevetoxins are illustrated 
in Figures 2.7 and 2.8. Upon collisional activation of the m/z 914 [brevetoxin-3 + NH4]+ 
precursor where ammonium ion has attached to the hydroxyl group (Figure 2.7), an ammonia 
molecule leaves the adduct to yield [brevetoxin-3 + H]+ at m/z 897. Subsequent water loss 
produces a fragment at m/z 879, and ensuing fragmentation results in m/z 751 or m/z 769 (Figure 
2.7). The latter two ions may also be formed during direct compositions of the [brevetoxin-3 + 
H]+ precursor. Analogous mechanisms apply to the brevetoxin-2 ammonium adduct at m/z 912 
and protonated brevetoxin-2 at m/z 895, to yield in both cases, analogous fragments at m/z 877, 
m/z 769 and m/z 751 (Figure 2.6).  
 
Originating either directly from the protonated precursor [brevetoxin-3 + H]+, or in the case 
where ammonia is lost from the initial [brevetoxin-3 + NH4]+ adduct and the excess proton 
becomes localized on the oxygen atom at ring H, the protonated ether oxygen will initiate 
subsequent fragmentation to yield m/z 473, as illustrated in Figure 2.8. Ammonium ion may also 
attach to the electron-rich double bond at the “tail” portion, and upon ammonia loss, can undergo 
fragmentation to yield m/z 825; subsequent water loss produces m/z 807 (Figure 2.8). These latter 
two fragment ions may also be produced from direct decompositions of the protonated 
brevetoxin-3 precursor (see figure 2.5b). Because the same sites of ammonium ion (or proton) 
attachment shown in Figure 2.8 are also available on brevetoxin-2, in principle, the analogous  
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Figure 2.6. Product ion spectra of (a) m/z 912 precursor, the ammonium adduct 
of brevetoxin-2, [brevetoxin-2 + NH4]+; and (b) m/z 895 precursor, protonated 
brevetoxin-2. The similarity of these two spectra indicates that the ammonium 
adduct first loses NH3, and then consecutive decompositions occur. 
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three decomposition pathways leading to m/z 473, 807 and 825 could apply to the latter 
neurotoxin; in practice, only the m/z 473 peak appeared in high abundance (see Figure 2.6). 
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Conclusions  
 
In this study, a sample-conserving nanoelectrospray method was developed to improve CID 
efficiency and the ability to deduce structural information from brevetoxins. The abundant 
sodium adducts typically observed during ES of brevetoxins do not efficiently  yield product ions 
upon CID. Via addition of ammonium fluoride, ammonium ions were found to form cationic 
adducts with brevetoxins at very low cone voltages, reaching a maximum abundance at 20 V. 
When the cone voltage was further raised, the abundance of ammonium adducts decreased, while 
the abundance of protonated brevetoxin increased to become the base peak. The method thus 
allows the production of protonated brevetoxins under mild solution conditions (near neutral 
pH). These protonated brevetoxins readily underwent CID fragmentation, and they yielded 
similar product ions as compared to their ammonium adduct counterparts. This latter result 
indicates that the first step in ammonium adduct decomposition is loss of ammonia to form 
protonated brevetoxin which can undergo consecutive fragmentations. The addition of 
ammonium fluoride combined with the use of moderate cone voltages can markedly improve the 
ability to obtain structural information by ES-MS/MS from brevetoxins and other sodium-
scavenging, robust compounds. 
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Chapter III 
 
 
 
Enhanced CID Efficiency and Unraveling of Novel Fragmentation Pathways 
of Brevetoxins in Negative Ion Electrospray Mass Spectrometry 
 
 
 
 
 
Abstract 
 
Brevetoxins are a group of natural neurotoxins characterized by polyether ring systems that are 
found in the blooms of red tide algae. In a conventional water/organic solvent system, without 
any other additives, deprotonated molecules of brevetoxins do not appear in high abundance in 
negative mode electrospray-mass spectrometry (ES-MS ) due to lack of acidic functional groups, 
thus they are not well-suited for collision induced dissociation (CID) experiments in negative 
mode electropsray. In this study, several anions were tested for their abilities to form anionic 
adducts by mixing ammonium salts of these anions with brevetoxin-2 and brevetoxin-3. Under 
CID, [M + Br]-, [M + OAc]-, [M + HCOO]-, and [M + NO3]- adducts all produced only the 
respective anions in CID experiments, and thus provided no structural information. In contrast, 
upon CID, both [M + F]- and [M + HCO3]- precursor adducts gave structurally-informative 
fragment peaks that exhibited similarities to those of  [M - H]- ions, which indicated that the first 
step in gas phase decomposition of these anionic adducts was loss of neutral HF or H2CO3 
molecules, respectively, leaving deprotonated brevetoxin [M - H]- to undergo consecutive 
fragmentations. Compared to bicarbonate adducts, fluoride adducts provided more fragment 
peaks, thus more structural information. It is therefore the anion of choice to study brevetoxins in 
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negative mode electrospray mass spectrometry using the anionic adduct approach. The detailed 
fragmentation mechanisms are discussed; optimum values of cone voltage and anion 
concentration were determined. To test the developed methodology, a sample of brevetoxin-2 
subjected to in vitro microsomal incubation was analyzed and identified as brevetoxin-3, a 
reduction product of the substrate. 
 
Key words:  mass spectrometry, negative ion electrospray, brevetoxins, anionic adducts,  
LC-MS/MS. 
 
 
 
 
 
3.1 Introduction 
 
Brevetoxins are a family of lipid-soluble, polycylic ether marine neurotoxins that are produced 
from the single cell dinoflagellate Karenia brevis (formerly known as Ptychodiscus brevis and 
Gymnodinium breve)[1] [2]. Under suitable conditions of temperature and salinity, the algae may 
reproduce rapidly, causing a “red-tide” bloom, a phenomenon that was documented by Spanish 
explorers along the Florida Gulf coast as far back as the 1530s [3];  reports of red-tide induced 
marine mammal toxicity can be dated back to 1844 [4] [5]. Such harmful algal blooms can cause 
periodic massive fish kills along the Gulf of Mexico coast and other salt water locations [6] [7], 
in fact, blooms containing 0.2 million cells/Liter of Karenia brevis effectively kill fish [8]. 
Consumption of shellfish contaminated by brevetoxins leads to neurotoxic shellfish poisoning in 
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humans [9] [10] . In addition, due to the fragile nature of dinoflagellates, Karenia brevis cells 
can be broken during more violent wave motions, thereby releasing brevetoxins into open water 
[11], as well as creating a toxin-containing aerosol [12]. Humans living in coastal areas will 
experience respiratory irritation and other symptoms when inhaling such an aerosol [13] [14].  
 
At least 9 brevetoxins have been found and their structures fully elucidated, their structures can 
been seen in our previous publication [15]. Among them, brevetoxin-1 is the most toxic one and 
brevetoxin-2 is the most abundant in the red tide bloom [16]. Based on two different backbone 
structures, brevetoxins can be classified as either type A, which has a 10-ring polyether system, 
and type B, which has 11 polyether rings [17].  
 
A variety of analytical methods have been developed to measure brevetoxins, from functional 
assays such as the mouse bioassay that has been used to monitor the level of brevetoxin in 
shellfish [18], to immunoassays such as radio-immunoassay [19] and ELISA [20] that have been 
used to detect brevetoxins in sea water, shellfish and mammalian body fluid. However, direct 
chemical analysis of brevetoxins, especially mass spectrometry-based methods that have 
inherently high specificities certainly are advantageous, and have become the major analytical 
method of choice.  
 
Dickey et al. [21] developed a method of HPLC-FAB-MS to study brevetoxin-3 by employing 
derivatizing agents in the early 1990s. Later, a liquid chromatography–electrospray-mass 
spectrometry (LC-ES-MS) was developed in our lab to directly analyze the various types of 
brevetoxins in red-tide extracts [22, 23]. Poli et al. [19] reported using LC-MS to identify 
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brevetoxin-3 in shellfish, a likely metabolite of brevetoxin-2. Plakas et al. [24, 25] exposed 
Eastern oysters (Crassostrea virginica) to brevetoxin-2, where the toxin was extensively 
metabolized. LC-MS fractions contained m/z 1018 and 1034 representing protonated molecules 
of cysteine-brevetoxin and cysteine-brevetoxin sulfoxide conjugates, respectively. In a follow up 
paper, Wang et al. [26] identified several amino acid conjugates of brevetoxins, as well as other 
metabolites such as glutathione and related peptide conjugates. To date, most accounts of mass 
spectrometry-based brevetoxin analyses are focused on positive mode electrospray. In our lab, 
brevetoxin-1 and brevetoxin-2 were found to form metabolites via rat liver hepatocytes and rat 
liver microsomal incubations, respectively [27]. They were first studied in the positive ion mode. 
We also elucidated certain acidic products resulting from hydrolytic lactone-ring (A-ring) 
opening by negative mode tandem mass spectrometry [27]. Abraham et al. [28] later reported the 
existence of open A-ring brevetoxin analogues in Karenia brevis cultures and in natural blooms 
by using solid phase extraction (SPE) and LC-MS/MS. Such fractions are rather polar and were 
poorly extractable by conventional non-polar solvents like chloroform. 
 
Due to the unique molecular architecture of brevetoxins, including multiple ether linkages, they 
exhibit a high affinity toward sodium ions and readily form sodium adducts [M + Na]+. Without 
sample pre-treatment, even just trace levels of ubiquitous sodium, will result in [M + Na]+ ions 
dominating the positive mode electrospray mass spectrum. Sodium adducts of brvetoxins, 
however, are quite resistant to decomposition, even under higher energy collision induced 
dissociation (CID); Under harsh collision conditions, they tend to produce mostly sodium ions, 
without significant yields of structurally-informative fragments [29].  
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To promote the signals of protonated brevetoxins over sodium adducts, various approaches have 
been employed. In our lab, we treated brevetoxins with strong acid to favor production of [M + 
H]+ ions that were shown to readily fragment under moderate (50-70 eV) CID conditions [30]. 
After our report, Nozawa and coworkers [31] and Ishida and coworkers [32] promoted 
[brevetoxins + H]+ ions by adding formic acid to the LC-MS/MS mobile phase, while Radwan et 
al. [33] used a mobile phase containing acetic acid to perform LC-MS/MS multiple reaction 
monitoring (MRM). In later work, we developed an alternative method employing 
nanoelectrospray where ammonium salts of selected anions were added to the solvent to promote 
the formation of protonated brevetoxin molecules and ammonium adducts [15]. Ammonium 
adducts of brevetoxins produced fragmentation patterns similar to those of the protonated 
brevetoxins. The latter procedure avoided the drawbacks of analyzing strongly acidic solvents 
and reduced the level of sample consumption. 
 
An alternative way to study brevetoxins by electrospray mass spectrometry is to use the negative 
ion mode of operation, however, such studies are still rare. Because brevetoxins do not have 
acidic functional groups, e.g. carboxylic acid moieties, without further treatment, deprotonated 
brevetoxins are not formed in high enough yields for CID study. Although adding base to the 
system is a common technique to enhance deprotonation, it increases the risk of hydrolysis 
reactions. On the other hand, for compounds that lack acidic sites, anion attachment can be a 
practical approach to negative mode ES mass spectrometric analysis [34]. Although evidence of 
anion attachment in negative mode electrospray can be traced back to Yamshita and Fenn’s work 
in 1984 [35], this area, as well as negative mode electrospray in general, has received far less 
attention than positive mode endeavors, partially due to the lower stability of negative mode 
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electrospray signals, caused by an added tendency toward electrical (corona) discharge. 
Nevertheless, negative ion electrospray may provide a totally different view to improve 
understanding of the analyte. In this study, several types of anions were employed to undergo 
attachment with brevetoxin molecules. We report on the success of various anionic adducts in 
providing useful structural information concerning brevetoxins in negative mode electrospray 
tandem mass spectrometry. 
 
3.2 Experiment 
 
Brevetoxins were purchased from CalBiochem (La Jolla, CA), and ammonium fluoride, 
ammonium acetate, ammonium bicarbonate, ammonium chloride, ammonium bromide, 
ammonium formate, ammonium nitrate and ammonium hydroxide were all purchased from 
Aldrich (Milwaukee, WI). All mass spectrometry experiments were performed on a Quattro II 
and Quattro micro “triple quadrupole” (quadrupole-hexapole-quadrupole) mass spectrometer 
equipped with an electrospray ionization source (Micromass/Waters Inc. Manchester, UK). The 
flow rate for direct infusion was set at 1 μL/min. Nitrogen gas was employed as both drying gas 
and nebulizing gas; the ES “needle” voltage was set at 2.7 kV. Collision-induced decomposition 
(CID) tandem mass spectra were acquired using argon as collision gas at a pressure of 2.1 x 10-2 
Pa on Quattro II instrument and 0.25 Pa on Quattro micro instrument (gauge external to hexapole 
collision cell). All mass spectra represent the average of 10 to 20 scans. M/z values were rounded 
down (truncated) to the nearest integer values, that is, the nominal masses of the fragment ions 
are reported in the spectra.  
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To test the developed method on a real sample of biological significance, brevetoxin metabolites 
were generated by conducting in vitro incubations of brevetoxin-2, using rat liver microsomes 
purchased from Gentest Corp. (Woburn, MA). After incubation, the samples containing substrate 
and metabolites were cleaned up by adding ice cold methanol, and then passing the supernatant 
through a Microcon YM-3 filter (Pittsburgh, PA) to remove proteins in preparation for LC-
MS/MS analysis. The details of microsomal incubation of brevetoxin-2 and LC-MS mobile 
phase conditions can be found elsewhere [27]. 
 
3.3 Results and Discussion 
 
The acidity (or basicity) of a compound plays an important role in electrospray mass 
spectrometry. Generally speaking, positive mode electrospray is suitable for molecules with 
enough basicity to readily attract an ionizing proton, whereas negative mode electrospray is a 
good choice for compounds of high acidity. However, for compounds that lack an acidic 
functional group, for example, neutral oligosaccharides, without the aid of a base to promote 
deprotonation, their [M - H]- signals in negative mode electrospray are usually poor. Previous 
research has shown that anion attachment is a very useful approach to making such analytes 
“visible” in negative mode electrospray mass spectrometry.  
 
A series of studies [34, 36-40] conducted in our lab has shown that factors such as a matching of 
the gas phase basicities of the deprotonated analyte and the selected anion, and the propensity to 
form hydrogen bonds are critical for the formation and stability of anionic adducts. Follow-up 
computational studies also helped to understand such analyte-anion adducts [34, 39]. We have  
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Figure 3.2   A) Negative mode product ion spectrum of m/z 913 precursor, the 
fluoride adduct of brevetoxin-2 standard [brevetoxin-2 + F]-.  B) product ion 
spectrum of m/z 915 precursor, the fluoride adduct of brevetoxin-3 standard. 
[brevetoxin-3 + F]-. 
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[brevetoxin-3 + FHF]-. 
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employed chloride ions for attachment to disaccharides, and decompositions of disaccharide-
chloride adducts gave diagnostic glycosidic bond linkage information[38, 41] including 
anomeric configuration [42]. Murae et al. [43] reported using both chloride and bromide to 
characterize tetraether lipids in archaea membrane. Harvey [44] tried different anions to study N-
linked glycans and found that nitrate adducts gave satisfactory signals in negative ion 
electrospray, i.e., 10-fold stronger signals than from the corresponding [M - H]- ions formed with 
the assistance of added ammonium hydroxide. Sheen and Her [45] analyzed several neutral drugs 
in plasma by liquid chromatography-negative ion electrospray-tandem mass spectrometry, with 
the approach of adding fluoride to promote [M + F]- adducts; good detection limits and linearity 
were observed.  
 
Anion of Choice 
 
Building upon our previous experience with anion attachment in negative ion ES-MS [34, 36-
42], including specific experience with fluoride attachment [40], for the brevetoxin samples 
under investigation, the first system that we examined was brevetoxin - NH4F. In addition to 
producing abundant [M + F]- adducts, further CID experiments showed that both [brevetoxin-2 + 
F]- and  [brevetoxin-3 + F]- precursors gave structurally-informative fragments (as demonstrated 
in figures 3.2a and 3.2b). The fragmentation patterns were very similar to those of the 
corresponding [M - H]- precursors generated by addition of ammonium hydroxide, shown in 
Figures 3.3a and 3.3b. The similarities in the two pairs of CID spectra indicate that the first step 
of the decomposition of [M + F]- adducts in the gas phase was to lose hydrogen fluoride and  
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Graph 1.  Electrospray mass spectra of (brevetoxin-3 - NH4F) system as a function of 
cone voltage. The concentration of brevetoxin-3 was set at 5 x 10-5 M in a 1:1 
water/acetonitrile solution, and the cone voltage was set at (A) 10 V, (B) 40 V, and (C) 
60 V. The abundances of deprotonated brevetoxin-3 (m/z 895) and its fragments (m/z 
877 and m/z 859) increased, whereas those of [brevetoxin-3 + FHF]- (m/z 935) and 
[brevetoxin-3 + F]- (m/z 915) decreased, as the cone voltage was raised. 
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thereby form [M - H]-. Afterwards, consecutive fragmentations of these deprotonated molecules 
yielded products similar to those appearing in figure 3.3a and 3b. 
 
The production of [brevetoxin - H]-, along with the absence of F- observed in the product ion 
mass spectra of [brevetoxin-2 + F]- (figure 3.2a) and [brevetoxin-3 + F]- (figure 3.3b) precursors 
indicates that the gas-phase basicity of deprotonated brevetoxin-2 and brevetoxin-3 are lower 
than that of fluoride. The strong basicity of the fluoride anion allows it to easily capture a proton 
from neutral brevetoxin and depart as HF.  
 
In the same brevetoxin - NH4F system, in the low cone voltage range (e.g. 10-20 V), the 
presence of [M + 39]- adduct ions  was also observed (graph 1a). CID of such adduct precursors 
showed both [M + F]- and m/z 39 peaks (figure 3.2c, 3.2d), which indicated that this adduct was 
the [M + FHF]- ion, and m/z 39 was the FHF- ion. Such FHF- clusters were first detected by 
Larson and McMahon in 1983 [46], Caldwell and Kebarle [47] studied the gas - phase 
equilibrium of F- + HF ↔ FHF- in the mid 1980’s using a high pressure mass spectrometer, and 
Li et al. [48] have calculated that the bond angle of the FHF- ion cluster is very close to linear at 
179.4°. Clearly, the FHF- ion has a lower gas-phase basicity than that of fluoride ion, as it is 
visible in the product ion scans (figures 3.2c and 3.2d). CID of such adducts also provided 
structurally-informative fragments, although in lower yields, than direct decompositions of the 
fluoride adducts (figures 3.2a and 3.2b). 
 
In addition to fluoride, we also attempted to find other anions capable of forming brevetoxin-
anion adducts, which hopefully would also provide informative fragmentation, and bicarbonate  
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Figure 3.3 A) Negative mode product ion spectrum of m/z 893 precursor,  
deprotonated brevetoxin-2, promoted by adding ammonium fluoride, inset, product 
ion spectrum of m/z 893, promoted by adding ammonium hydroxide. 
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Figure 3.3 continued. B) product ion spectrum of m/z 895 precursor, 
deprotonated brevetoxin-3 promoted by adding  ammonium fluoride; inset, tandem 
mass spectrum of m/z 895, promoted by ammonium hydroxide addition). 
 
is another anion that was tested for this purpose. In figure 3.4, it is shown that both [brevetoxin-2 
+ HCO3]- at m/z 955 and [brevetoxin-3 + HCO3]- at m/z 957 can give structurally-informative 
brevetoxin fragments upon CID. The patterns of fragmentation are similar to those of the 
corresponding deprotonated brevetoxins, shown in figure 3.3. This is evidence that, for 
bicarbonate adducts, losing neutral carbonic acid is the first step of fragmentation (as was also 
the case for fluoride adducts losing HF). Interestingly, a peak corresponding to water loss from 
[brevetoxin-2 + HCO3]- adducts can be seen at m/z 937 (figure 3.4a), but no such peak is visible 
for [brevetoxin-3 + HCO3]- adducts at m/z 939 (figure 3.4b). 
 
Experiments with other anions showed that brevetoxins would also form anionic adducts with 
chloride, bromide, formate, acetate and nitrate that were detectable in negative mode 
electrospray. However, under CID conditions, such precursor adducts only produced the 
respective anions and could not provide structural information (chloride adducts are shown as 
examples in figure 3.5). Based on these experiments, we can infer that the gas phase basicities of 
deprotonated forms of brevetoxin-2 and brevetoxin-3 are higher than those of chloride, bromide, 
formate, acetate and nitrate anions, but are lower than those of fluoride and bicarbonate, this 
situates the proton affinity of deprotonated brevetoxin-2 and deprotonated brevetoxin-3 
somewhere between 1523 kJ/mol (bicarbonate) and 1427 kJ/mol (acetate); the gas phase 
bascities of the studied anions are listed in Table 1. 
 
In comparing the product ion spectra of fluoride (Figures 3.2a and 3.2b), and bicarbonate 
(Figures 3.4a and 3.4b) adduct precursors of brevetoxins, fluoride adducts provide more  
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Table 1. Gas-Phase Bascities of Some Anions 
Anion Gas Phase Bascity 
(KJ/mol) 
Fragmentation of anionic 
adducts 
Fluoride 1530.5 ± 1.3 Observed 
Bicarbonate 1523 ± 8.4 Observed 
Acetate 1427 ± 8.4 Not detected 
Formate 1416 ± 8.4 Not detected 
Chloride 1372.8 ± 0.84 Not detected 
Bromide 1331.8 ± 0.84 Not detected 
Nitrate 1329.7 ± 0.84 Not detected 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.  Gas-phase basicities of anions employed in this study [49]. 
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fragment peaks and more structural information in CID experiments. It is therefore the anion of 
choice to analyze brevetoxins in negative mode electrospray by the anionic adduct approach. 
 
 
 
Fragmentation pathways 
 
Detailed fragmentation studies of complicated molecules such as the brevetoxins are important to 
identify or confirm their structures; they are also very useful to deduce the structures of 
metabolites. When structural modifications occur during metabolism, the MS/MS spectrum of 
the metabolites can readily reflect the alterations. By comparing MS/MS spectra of the 
metabolites with the fragmentation patterns of the starting compound, mass shifts of certain 
peaks can give an indication of the sites at which biotransformations take place. Moreover, the 
peaks that appear at the same masses for the metabolites and starting material can indicate 
portions of the molecule that are not altered.  Detailed mechanisms to rationalize fragmentations 
of the two studied brevetoxins are illustrated in Schemes 1, 2 and 3. Upon collisional activation 
of the m/z 915 [brevetoxin-3 + F]- precursor where fluoride ion has attached to the hydroxyl 
group (Scheme 1), a hydrogen fluoride molecule first leaves the adduct to yield [brevetoxin-3 - 
H]- at m/z 895.  The negative charge left on the oxygen then initiates a charge-driven 
fragmentation, yielding m/z 97 ions. The analogous mechanism also applies to [brevetoxin-2 + 
F]- adducts and results in the peak at m/z 95. Another possible site for fluoride attachment is the 
allylic hydrogen on the “tail” portion of the brevetoxin molecule (scheme 1, Pathway 2). After 
HF loss and subsequent water loss, the negative charge on the allylic site of m/z 875 ion may 
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undergo another charge driven-fragmentation. After J-ring opening, the negative charge may 
have a Michael reaction-like ring formation step (scheme 1), and after a hydrogen transfer, a 
seven-membered ring with a stable conjugate double bond system is formed (m/z 135 fragment, 
scheme 1). The analogous route will  lead to the m/z 133 for [brevetoxin-2 + F]- adducts (figure 
3.2a) and [brevetoxin-2 + HCO3]- (figure 3.4a). 
 
In scheme 2, another mechanism was proposed, fluoride ion first attaches to the allylic hydrogen 
at the tail part and leaves as a neutral molecule. The remaining negative charge then may take a 
different route and break the O-C bond in the J-ring, forming an ion-dipole complex. The 
dissociation of this complex will result in m/z 741 (figures 3.2a and 2b), but if proton transfer 
occurs, it will yield m/z 151 for [brevetoxin-2 + F]- adducts (figure 3.2a) or m/z 153 for 
[brevetoxin-3 + F]- adducts (figure 3.2b). 
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Scheme 1. Proposed fragmentation pathways for [Brevetoxin-3 + F]-, leading to 
m/z 97 and 135. A similar route also applies to m/z 95 and 133 formation from 
[Brevetoxin-2 + F]- and for deprotonated brevetoxins after ammonium hydroxide 
addition. 
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Scheme 2. Proposed fragmentation pathways for [Brevetoxin-2 + F]-, leading to 
m/z 151 and 741. Similar routes also apply to [Brevetoxin-3 + F]-, yielding m/z 
153 and 741 respectively and for deprotonated brevetoxins after ammonium 
hydroxide addition.  
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 Generated either directly from the deprotonated precursor [brevetoxin-3 - H]- at m/z 895, or as 
shown in Scheme 3, where carbonic acid is lost from the initial [brevetoxin-3 + HCO3]- adduct 
and the negative charge becomes localized on the oxygen atom attached to the K-ring, the 
residing charge breaks open the  K-ring, causing the loss of its “tail” portion as an alkene. This 
produces the m/z 797 peak (figures 3.4a and 3.4b) and analogous ions in figures 3.2a, 3.2b, 3.3a 
and 3.3b. The ensuing charge driven fragmentation may break ring J (scheme 3) and yield m/z 
725 peak (scheme 3). Another possible pathway is that after ring J is broken, the charge on the 
tertiary carbon may initiate two-hydrogen-transfers to produce the peak at m/z 739 (scheme 3). 
In fact, these two peaks are not only seen in the product ion scans of [M + HCO3]- adducts, but 
also in the MS/MS spectra of [M + F]-, [M + FHF]-, and [M - H]- ions, and m/z 739 usually 
appears in higher abundance than m/z 725.  
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Scheme 3. Proposed fragmentation mechanisms for [Brevetoxin-3 + HCO3]- yielding 
m/z 797, 725 and 739. Analogous pathways also can apply to [Brevetoxin-2 + HCO3]- 
and fluoride adducts. 
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Influence of Cone Voltage 
 
 
 
The optimization of experimental parameters in negative electrospray mass spectrometry is quite 
important to obtaining high signal-to-noise ratios. One critical parameter is the potential 
difference between the sampling cone and skimmer i.e. the so-called “cone voltage” or nozzle-
skimmer voltage. A detailed study of the effect of this voltage on observed signals of three 
relevant ions was conducted using a water/acetonitrile system (1:1 by volume) containing 0.05 
mM brevetoxin-3 (896 Da neutral) and a concentration of 0.5 mM ammonium fluoride (figure 
3.6A and graph 1). The bifluoride adduct [brevetoxin-3 + FHF]-, at m/z 935, was the first 
component to reach its maximum abundance at 20 V, and then it dropped off quickly. The 
abundance of [brevetoxin-3 + F]-, at m/z 915, on the other hand, kept increasing with voltage 
until it reached its peak at 40 V. This is partially due to the instability of [brevetoxin-3 + FHF]- 
which dissociated to yield [brevetoxin-3 + F]- when the cone voltage was raised above 20 V to 
help elevate the m/z 915 signal. As the cone voltage increased beyond 40 V, [brevetoxin-3 + F]- 
underwent in-source CID, yielding [brevetoxin-3 - H]-, at m/z 895.  The resulting [brevetoxin-3 - 
H]- exhibited the highest signal at 60 V; after this point, an increasing cone voltage resulted in in-
source CID that imparted energy high enough to break covalent bonds, and the abundance of [M 
- H]- began to fall. The experiment with brevetoxin-2- NH4F system showed similar results, with 
optimal cone voltage for [brevetoxin + FHF]-, [brevetoxin-3 - H]- and [brevetoxin-3 + F]- at 20, 
40 and 60 V respectively. These respective values were used as the operating cone voltages when 
MS/MS experiments were conducted on the corresponding precursors.  
 100
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.0E+00
2.0E+04
4.0E+04
6.0E+04
8.0E+04
1.0E+05
1.2E+05
1.4E+05
10 20 30 40 50 60 70 80 90 100
Cone voltage
A
bs
ol
ut
e 
ab
un
da
nc
e
m/z 895, [Brevetoxin-3 -H]- ,  
m/z 915, [Brevetoxin-3 + F]-
m/z 915,  
[Brevetoxin-3 +FHF]- 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.0E+00
5.0E+04
1.0E+05
1.5E+05
2.0E+05
2.5E+05
3.0E+05
3.5E+05
0 5 10 15 20 25 30 35
Molar ratio (anion : brevetoxin-3)
ab
so
lu
te
 a
bu
nd
an
ce
m/z 895, [Brevetoxin-3 - H]- , fluoride addition 
m/z 895, [Brevetoxin-3 - H]-, hydroxide addition 
B 
 
 
 
 
 
 
 
 
 
Figure 3.6. A) Ion abundance vs. cone voltage for brevetoxin-3 molecular ions 
from a 1:1 water/acetonitrile system containing 0.05 mM brevetoxin-3, and 0.5 
mM NH4F. The abundance of [brevetoxin-3 + FHF]- reaches its maximum at 20 
V, the abundance of [brevetoxin-3 + F]- reaches its maximum at 40 V, whereas 
that of [brevetoxin-3 - H]- reaches its maximum at 60 V. B) Absolute 
abundances of molecular ions of brevetoxin-3 vs molar ratio of anion : 
brevetoxin-3, cone voltage was set at 60V,  
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Figure 3.6. continued  C) Absolute abundances of fluoride adducts of 
brevetoxin-3 vs molar ratio of fluoride : brevetoxin-3 at 40 V cone voltage. The 
concentration of brevetoxin-3 was set at 0.05 mM, while the concentration of 
NH4F and NH4OH was varied from 0 to 1.5 x mM. The cone voltage was set at 
60 V. The abundance increase of [M - H]- slows beyond 10:1, and NH4F serves 
better than NH4OH to yield [M - H]- in high abundance. 
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Anion ratio study 
 
Because brevetoxins are quite expensive reagents, in another experiment, we tried to optimize 
the addition of fluoride ions to achieve the highest signal intensity at low level brevetoxin 
concentrations. One series of mixtures are water/acetonitrile solutions (1:1 by volume) 
containing a fixed concentration of brevetoxin-3 (0.05 mM) and increasing concentrations of 
ammonium fluoride.  The other series of mixtures are water/acetonitrile solutions (1:1 by 
volume) containing the same concentration of brevetoxin-3 and increasing concentrations of 
ammonium hydroxide. Under a fixed cone voltage of 60 V (i.e. the optimum value for 
[brevetoxin-3 - H]- drawn from Figure 3.6a), Figure 3.6b shows that when there was no additive 
in the system,( i.e. molar ratio on x-axis = 0 for plain organic/water solution), the signal of m/z 
895, deprotonated brevetoxin-3 was low. Adding an amount of either ammonium fluoride or 
ammonium hydroxide equal to the analyte concentration each promoted the production of 
[brevetoxin-3 - H]- and in similar abundance. However, further increasing the concentration of 
hydroxide didn’t increase [brevetoxin-3 - H]- significantly. In contrast, further increasing the 
fluoride concentration kept promoting the formation of [brevetoxin-3 - H]-. This trend began to 
level off after a 10:1 molar ratio, but still slowly increased until 30:1.  From Figure 3.6b, it can 
be see that fluoride is a more efficient additive to promote the formation of [brevetoxin-3 - H]- 
compared to the commonly used weak base ammonium hydroxide. 
 
When employing a fixed cone voltage of 40 V, the optimum value for the formation of [M + F]- 
(from figure 3.6a), a test similar to the one above showed that the abundance of the [M + F]-  
brevetoxin-3 adduct increased rapidly as the fluoride: brevetoxin-3 ratio changed from 0 to 15:1 
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(Figure 3.6c). At higher molar ratios, a leveling off of [M+F] – signal was observed, and the extra 
ammonium fluoride will elevate the conductivity of the solution unnecessarily. Combining the 
two studies above, it is concluded that the optimal condition to study brevetoxins in negative 
mode electrospray mass spectrometry is to add a 10-15 fold excess of ammonium fluoride 
(relative to analyte concentration) to the solution and perform CID on the fluorideadducts at a 
cone voltage of 40 V, or on the deprotonated molecules at 60 V. 
 
Metabolite sample analysis 
 
 Our previous study of microsomal brevetoxin-2 metabolites has elucidated the structure of one 
metabolite, brevetoxin-2-M1 as a hydrolysis product of brevetoxin-2 with A-ring opening [27]. 
Based on its retention time and mass, which are the same as those of a brevetoxin-3 standard, the 
other metabolite, brevetoxin-2-M2 was postulated to have the same structure as brevetoxin-3. By 
applying the fluoride adduct approach (using 0.1 mM ammonium fluoride in stead of water as 
mobile phase A), we analyzed an identically prepared microsomal metabolite sample in negative 
mode ES-MS, and obtained the product ion scan of brevetoxin-2-M2. The LC-MS traces of the 
brevetoxin-2 incubation sample are shown in Figure 3.7. Two main metabolite peaks were 
observed in addition to the peak representing unreacted brevetoxin-2. The selected ion 
chromatogram (SIC) of m/z 911 showed the peak at 4.5 min (figure 3.7b), which represents the 
metabolite brevetoxin-2-M1. The SIC of m/z 913, revealed the fluoride adduct of brevetoxin-2 at 
8.5 min (figure 3.7c), while the SIC of m/z 915, showed the fluoride adduct of the 2nd metabolite 
brevetoxin-2-M2 at 7.7 min (figure 3.7d), its retention time matches that of brevetoxin-3  
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Figure 3.7. Negative mode electrospray LC-MS chromatograms for brevetoxin-
2 sample that has undergone incubation with rat microsomes. a) TIC for 
incubation sample; b) SIC of m/z 911 from the incubation sample. The peak at 
4.47 min represents metabolite brevetoxin-2-M1 (identified elsewhere as 
hydrolysis product with lactone “A” ring opening); c) SIC of m/z 913 from the 
incubation sample. In this chromatogram, the peak at 8.50 min represents the 
fluoride adduct of unreacted brevetoxin-2, whereas the peak at 4.47 min is the 
M+2 peak of brevetoxin-2-M1. d) SIC of m/z 915, metabolite [Brevetoxin-2-M2 
+ F]-, that elutes at 7.73 min. The peak at 8.50 min is the M+2 peak of unreacted 
[brevetoxin-2 + F]-. e) In a separate run, TIC for fluoride adduct of brevetoxin-3 
standard, its retention time (7.73 min) is the same as that of [brevetoxin-2-M2 + 
F]-.  
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Figure 3.7. Continued  f) LC-MS/MS negative mode product ion mass 
spectrum of m/z 915 at 7.73 min, [Brevetoxin-2-M2 + F]- from 7d above. The 
spectrum is very similar to that of the fluoride adduct of brevetoxin-3 standard 
(Fig. 2b). This indicates that Brevetoxin-2-M2 has the same structure as 
brevetoxin-3.  
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standard at the same LC-MS condition, which is shown in figure 3.7e; Moreover, CID of the 
fluoride adduct precursor of this metabolite shows a very similar fragmentation pattern to that of 
fluoride adducts of brevetoxin-3. It therefore confirmed our previous postulation that metabolite 
brevetoxin-2-M2 is actually brevetoxin-3, a metabolic reduction product of brevetoxin-2. 
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Conclusion 
 
In this study, an electrospray mass spectrometry method was developed to enhance the CID 
performance of brevetoxins in negative mode electrospray, as well as to provide a different 
means to deduce structural information from brevetoxins. In a conventional water/organic 
solvent system, without the aid of a base, the abundances of brevetoxin ions are not strong 
enough for tandem MS studies. We have found that brevetoxins may form anionic adducts with 
fluoride, bicarbonate, chloride, bromide, formate, acetate and nitrate, although upon CID, [M + 
Cl]-, [M + Br]-, [M + OAc]-, [M + HCOO]-, [M + NO3]- adducts only produced respective anions 
and do not provide structurally-informative fragments. On the other hand, both [M + F]- and [M 
+ HCO3]- adducts underwent fragmentations that yielded product ions that are similar to those of 
deprotonated brevetoxins, which indicated that the first step of gas phase decomposition of these 
two adducts is losing a neutral HF or a H2CO3 molecule, respectively. In comparing the two 
adducts, the fluoride adduct showed more informative fragment peaks than its bicarbonate 
counterpart; it is therefore the anion of choice for anionic adduct approach. The optimal cone 
voltage for the formation of fluoride adducts is 40 V; further elevating the cone voltage resulted 
in a decrease of the fluoride adduct signal while the abundance of deprotonated brevetoxins 
would become the base peak. Thus, this method also allows the production of deprotonated 
brevetoxins under mild conditions (near neutral pH). Under the same additive concentration and 
cone voltage, the abundance of deprotonated brevetoxin was higher when adding ammonium 
fluoride than when adding ammonium hydroxide. The addition of ammonium fluoride combined 
with the use of suitable cone voltages can significantly improve the ability to obtain structural 
information by negative mode electrospray tandem mass spectrometry for brevetoxins. Detailed 
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fragmentation mechanisms were also proposed. With this approach of adding fluoride to the 
mobile phase of LC-MS/MS, by comparing the retention time and the product ion scan spectrum 
of a brevetoxins-3 standard with those of an unknown metabolite of brevetoxin-2 in vitro 
microsomal incubation sample, the metabolite was confirmed to be brevetoxin-3. 
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